Karampela, I.; Vallianou, N.G.; Tsilingiris, D.; Christodoulatos, G.S.; Psallida, S.; Kounatidis, D.; Stratigou, T.; Marinou, I.; Vogiatzakis, E.; Dalamaga, M.
Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications. Biomolecules 2024, 14, 291.
https://doi.org/10.3390/biom14030291
AMA Style
Karampela I, Vallianou NG, Tsilingiris D, Christodoulatos GS, Psallida S, Kounatidis D, Stratigou T, Marinou I, Vogiatzakis E, Dalamaga M.
Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications. Biomolecules. 2024; 14(3):291.
https://doi.org/10.3390/biom14030291
Chicago/Turabian Style
Karampela, Irene, Natalia G. Vallianou, Dimitrios Tsilingiris, Gerasimos Socrates Christodoulatos, Sotiria Psallida, Dimitris Kounatidis, Theodora Stratigou, Ioanna Marinou, Evaggelos Vogiatzakis, and Maria Dalamaga.
2024. "Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications" Biomolecules 14, no. 3: 291.
https://doi.org/10.3390/biom14030291
APA Style
Karampela, I., Vallianou, N. G., Tsilingiris, D., Christodoulatos, G. S., Psallida, S., Kounatidis, D., Stratigou, T., Marinou, I., Vogiatzakis, E., & Dalamaga, M.
(2024). Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications. Biomolecules, 14(3), 291.
https://doi.org/10.3390/biom14030291
